
zzso zzso zzso zzso zzso is a novel small zzso zzso inhibitor that is currently being tested in Phase II zzso With the recent publication of human zzso data from clinical studies, we now know the achievable levels and range of zzso exposure in zzso This study aimed to describe the zzso profile of zzso in mice in order to design zzso studies that zzso exposure levels in zzso 

Male zzso nude mice received subcutaneous zzso of zzso human melanoma zzso Once tumors reached zzso zzso mice were given a single dose of either 5 or 10 zzso zzso via oral zzso Additionally, a subset of mice was zzso once daily for 1 week (10 zzso Mice were killed and plasma and zzso were collected at various time points after the last zzso zzso were analyzed by zzso for zzso zzso Additionally, zzso zzso such as tumor proliferation and zzso zzso were analyzed at various time points after the last zzso 

After either a single dose or at steady state, at clinically equivalent zzso zzso effectively zzso zzso zzso and suppresses zzso Furthermore, we describe a zzso relationship between the zzso and the zzso of zzso and both target and zzso zzso 

The information presented zzso will drive the rational design of zzso studies that are not only relevant to the clinical setting, but also pave the way to understand the biological response to zzso zzso 

